Dr. Eric Zhou, MD

NPI: 1689674855
Total Payments
$72,458
2024 Payments
$5,474
Companies
48
Transactions
825
Medicare Patients
2,182
Medicare Billing
$218,361

Payment Breakdown by Category

Other$41,530 (57.3%)
Food & Beverage$23,115 (31.9%)
Consulting$5,500 (7.6%)
Travel$2,060 (2.8%)
Education$253.59 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $41,530 22 57.3%
Food and Beverage $23,115 779 31.9%
Consulting Fee $5,500 2 7.6%
Travel and Lodging $2,060 5 2.8%
Education $253.59 17 0.3%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $54,832 176 $0 (2024)
AstraZeneca Pharmaceuticals LP $3,735 155 $0 (2024)
Amgen Inc. $3,662 94 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,249 40 $0 (2024)
GlaxoSmithKline, LLC. $1,118 43 $0 (2024)
Lilly USA, LLC $1,085 46 $0 (2024)
Merck Sharp & Dohme LLC $822.37 44 $0 (2024)
Janssen Pharmaceuticals, Inc $729.60 30 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $703.89 25 $0 (2024)
Amarin Pharma Inc. $603.14 28 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,474 128 AstraZeneca Pharmaceuticals LP ($1,276)
2023 $3,385 113 Gilead Sciences, Inc. ($816.96)
2022 $2,749 113 Amgen Inc. ($690.16)
2021 $8,086 108 Gilead Sciences, Inc. ($5,930)
2020 $3,457 51 Gilead Sciences, Inc. ($2,707)
2019 $19,965 111 Gilead Sciences, Inc. ($18,259)
2018 $12,063 99 Gilead Sciences, Inc. ($10,605)
2017 $17,279 102 Gilead Sciences Inc ($15,833)

All Payment Transactions

825 individual payment records from CMS Open Payments — Page 1 of 33

Date Company Product Nature Form Amount Type
12/18/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.03 General
Category: RESPIRATORY
12/17/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $27.73 General
Category: Cardio-renal
12/14/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $29.17 General
12/11/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $24.49 General
Category: Inflammation
12/10/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $24.17 General
12/09/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $22.43 General
Category: GI
12/05/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $19.96 General
Category: Psychology/Psychiatric
12/03/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $26.99 General
12/02/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $140.15 General
Category: Psychology/Psychiatric
11/20/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.86 General
Category: RESPIRATORY
11/19/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Cardiology
11/16/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $31.82 General
11/14/2024 GlaxoSmithKline, LLC. AREXVY (Drug) Food and Beverage In-kind items and services $125.00 General
Category: RESPIRATORY
11/12/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $27.28 General
Category: DIABETES
11/11/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.98 General
Category: Respiratory
11/06/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $28.66 General
Category: Cardiovascular and Metabolism
11/05/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $22.20 General
Category: Inflammation
11/04/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $24.73 General
Category: Cardiovascular and Metabolism
10/30/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $29.95 General
10/30/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $29.87 General
Category: Cardio-renal
10/29/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Education In-kind items and services $6.80 General
Category: Cardio-renal
10/23/2024 Gilead Sciences, Inc. Vemlidy (Drug) Food and Beverage In-kind items and services $150.00 General
Category: HBV
10/23/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $28.89 General
Category: NEUROSCIENCE
10/22/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $28.49 General
10/17/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $119.78 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 293 513 $75,392 $31,659
2022 10 366 674 $94,806 $39,991
2021 15 796 1,270 $165,032 $79,083
2020 12 727 1,296 $163,430 $67,628
Total Patients
2,182
Total Services
3,753
Medicare Billing
$218,361
Procedure Codes
46

All Medicare Procedures & Services

46 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 66 218 $35,970 $13,433 37.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 31 31 $8,060 $4,529 56.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 27 43 $10,320 $3,652 35.4%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 26 46 $7,360 $3,297 44.8%
99497 Advance care planning, first 30 minutes Office 2023 39 41 $6,560 $2,213 33.7%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 11 11 $2,750 $2,063 75.0%
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free Office 2023 29 30 $1,807 $995.40 55.1%
G0008 Administration of influenza virus vaccine Office 2023 25 26 $1,560 $912.34 58.5%
36415 Insertion of needle into vein for collection of blood sample Office 2023 39 67 $1,005 $562.80 56.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 72 268 $44,220 $18,154 41.1%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 42 94 $15,040 $6,318 42.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 33 33 $8,580 $4,981 58.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 38 53 $12,720 $4,660 36.6%
99497 Advance care planning, first 30 minutes Office 2022 35 36 $5,760 $2,135 37.1%
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free Office 2022 32 32 $1,927 $1,009 52.3%
G0008 Administration of influenza virus vaccine Office 2022 29 29 $1,224 $1,004 82.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 17 20 $2,000 $800.78 40.0%
99441 Telephone medical discussion with physician, 5-10 minutes Office 2022 18 20 $2,000 $665.94 33.3%
36415 Insertion of needle into vein for collection of blood sample Office 2022 50 89 $1,335 $264.12 19.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 104 364 $58,725 $28,552 48.6%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 84 212 $33,020 $14,998 45.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 62 62 $16,120 $9,597 59.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 63 88 $20,200 $8,242 40.8%
99497 Advance care planning by the physician or other qualified health care professional, first 30 minutes Office 2021 78 91 $14,560 $5,332 36.6%
0013A Fee covid-19 vac 2 booster Office 2021 74 74 $5,921 $3,463 58.5%

About Dr. Eric Zhou, MD

Dr. Eric Zhou, MD is a Nephrology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689674855.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Zhou, MD has received a total of $72,458 in payments from pharmaceutical and medical device companies, with $5,474 received in 2024. These payments were reported across 825 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,530).

As a Medicare-enrolled provider, Zhou has provided services to 2,182 Medicare beneficiaries, totaling 3,753 services with total Medicare billing of $218,361. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Other Specialties Internal Medicine
  • Location New York, NY
  • Active Since 07/28/2005
  • Last Updated 07/17/2020
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1689674855

Products in Payments

  • Vemlidy (Drug) $46,779
  • Otezla (Drug) $1,463
  • FARXIGA (Drug) $1,391
  • JARDIANCE (Drug) $1,077
  • BREZTRI (Drug) $813.22
  • Prolia (Biological) $696.02
  • Repatha (Biological) $621.55
  • Vascepa (Drug) $603.14
  • XARELTO (Drug) $559.71
  • LOKELMA (Drug) $544.60
  • JANUVIA (Drug) $525.03
  • Kerendia (Drug) $515.85
  • TRULICITY (Drug) $461.96
  • EVENITY (Biological) $441.80
  • AIRSUPRA (Drug) $431.10
  • TRELEGY ELLIPTA (Drug) $393.40
  • Auvelity (Drug) $378.19
  • AREXVY (Drug) $373.55
  • Aimovig (Biological) $364.47
  • UBRELVY (Drug) $276.33

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in New York